Evaluating in Vivo PARP-1 Expression With 18F-FluorThanatrace Positron Emission Tomography (PET/CT) in Prostate Cancer
Clinical trial NCT03334500 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT03334500
- Sponsor
- Abramson Cancer Center at Penn Medicine
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-07-14
- Primary completion
- 2027-02-11
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.